The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.90
Bid: 248.60
Ask: 248.70
Change: 1.90 (0.77%)
Spread: 0.10 (0.04%)
Open: 248.10
High: 249.40
Low: 247.30
Prev. Close: 247.00
KGF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

3 Apr 2023 07:00

RNS Number : 0217V
Kingfisher PLC
03 April 2023
 

KINGFISHER PLC

Transaction in own shares

 

3 April 2023: Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 31 March 2023 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from BNP Paribas Exane, Intermediary Code: 969500UP76J52A9OXU27 ("BNP Paribas Exane") as part of its £300 million capital return programme announced on 23 May 2022 (the "Programme"). All shares were purchased by Kingfisher from BNP Paribas Exane as an "on-exchange" transaction in accordance with the rules of the London Stock Exchange.

Date of purchase:

31 March 2023

Total number of shares purchased:

43,400

Volume Weighted Average price paid per share:

GBp 259.2482

Highest price paid per share:

GBp 261.1000

Lowest price paid per share:

GBp 257.7000

 

To date, Kingfisher has purchased 19,867,641 ordinary shares in aggregate for cancellation from BNP Paribas Exane in connection with the third tranche of the Programme. Kingfisher also previously purchased 30,583,514 ordinary shares in aggregate for cancellation from Goldman Sachs International and 31,306,331 ordinary shares in aggregate for cancellation from Credit Suisse International in connection with its execution of the first and second tranches, respectively, of the Programme.

A schedule of individual trades carried out by BNP Paribas Exane as principal in connection with the above purchases is set out below.

Schedule of Purchases - Aggregate Information

Trading Venue

Number of Shares

Volume Weighted Average Price paid per share

XLON

43,400

GBp 259.2482

 

Schedule of Purchases - Individual Transactions

Price GBp

Time of each trade on 31 March 2023 (BST)

Trading venue

Quantity

Transaction Reference Number

260.5

07:02:26

XLON

1,766

00341076443EXPA1

259.5

07:19:37

XLON

2,939

00341079259EXPA1

259.1

07:51:59

XLON

1,946

00341085203EXPA1

258.8

08:26:19

XLON

2,128

00341091678EXPA1

258.7

08:38:59

XLON

1,686

00341094548EXPA1

258.7

08:55:45

XLON

1,746

00341098046EXPA1

258.3

09:17:22

XLON

1,650

00341102697EXPA1

258.2

09:48:01

XLON

41

00341109913EXPA1

258.2

09:49:40

XLON

726

00341110322EXPA1

258.2

09:49:40

XLON

1,088

00341110323EXPA1

257.7

10:05:06

XLON

970

00341114977EXPA1

257.7

10:05:06

XLON

1,013

00341114978EXPA1

258.4

10:21:06

XLON

1,753

00341118144EXPA1

259.1

10:45:02

XLON

2,368

00341122977EXPA1

258.6

11:08:21

XLON

1,814

00341128691EXPA1

258.8

11:39:17

XLON

2,219

00341137415EXPA1

258.8

11:54:15

XLON

442

00341141233EXPA1

258.8

11:55:12

XLON

2,253

00341141427EXPA1

259.8

12:29:35

XLON

1,486

00341149680EXPA1

259.7

12:40:09

XLON

2,115

00341153740EXPA1

259.0

13:19:20

XLON

1,800

00341165225EXPA1

259.0

13:19:20

XLON

645

00341165228EXPA1

259.4

13:39:50

XLON

2,071

00341174948EXPA1

260.9

14:09:02

XLON

2,446

00341188077EXPA1

260.6

14:24:25

XLON

2,145

00341194123EXPA1

260.3

14:51:58

XLON

532

00341208986EXPA1

261.1

15:14:06

XLON

1,612

00341222540EXPA1

 

 

Contacts:

Tel:

Email:

Company Secretary

+44 (0) 77 6880 6248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Treasury

+44 (0) 79 7767 8200

treasury@kingfisher.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKDFDFNDEFA
Date   Source Headline
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20245:05 pmRNSDirector/PDMR Shareholding
26th Apr 20245:00 pmRNSDirector/PDMR Shareholding
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 202411:00 amRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 202411:00 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 202412:03 pmRNSAnnual Financial Report & Notice of AGM
15th Apr 20247:00 amRNSDirectorate Changes
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:30 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:30 amRNSShare Repurchase Programme - Second Tranche
25th Mar 20247:00 amRNSFinal Results (Part 2 of 2)
25th Mar 20247:00 amRNSFinal Results (Part 1 of 2)
7th Mar 20249:00 amRNSDirector Declaration
1st Mar 202411:00 amRNSTotal Voting Rights
22nd Feb 20244:15 pmRNSHolding(s) in Company
9th Feb 202411:00 amRNSAppointment of Joint-Brokers
5th Feb 20245:15 pmRNSHolding(s) in Company
1st Feb 202412:00 pmRNSTotal Voting Rights
23rd Jan 20244:45 pmRNSDirector/PDMR Shareholding
12th Jan 202410:00 amRNSHolding(s) in Company
11th Jan 20247:05 amRNSFirst Tranche of Share Repurchase Programme
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 202410:15 amRNSTotal Voting Rights
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.